FEMY Femasys Inc

Femasys Inc., a biomedical company, researches, develops, and manufactures medical devices for the women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a sterile, single-use disposable endocervical curettage product; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

$7.02  -0.12 (-1.68%)
As of 10/27/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  06/18/2021
Outstanding shares:  11,799,720
Average volume:  15,436
Market cap:   $84,250,001
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    31447E105
ISIN:        US31447E1055
Sedol:      
Valuation   (See tab for details)
PE ratio:   -7.13
PB ratio:   2.61
PS ratio:   44.89
Return on equity:   -36.64%
Net income %:   -602.78%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy